Skip to content

Diabetes Scorecard Educational Intervention Study

Use of a Card to Improve Risk Factor Control in Patients With Type II Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01339520
Enrollment
104
Registered
2011-04-20
Start date
2008-11-30
Completion date
2010-05-31
Last updated
2017-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

The purpose of this study is to see if the use of a diabetic scorecard during clinic visits can improve glycemic control, blood pressure control, LDL-cholesterol, aspirin usage, and amount of exercise in adults over age 40 with uncontrolled Type II diabetes.

Interventions

BEHAVIORALScorecard

Points were assigned for blood pressure, HbA1c level, LDL-cholesterol level, aspirin use and exercise level.

BEHAVIORALControl

Standard of care for diabetes subjects

Sponsors

George Washington University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Uncontrolled Type II diabetes (HbA1c ≥ 8%)

Exclusion criteria

* Type I Diabetes * HbA1c \< 8% * Inability to understand the diabetes scorecard due to condition (i.e. dementia, mental retardation, etc) or language barrier * Pregnancy * Planning to move within the next year

Design outcomes

Primary

MeasureTime frameDescription
Change in total score9 monthsThe total score was calculated by points assigned to variables (systolic blood pressure, diastolic blood pressure, HbA1c, aspirin usage and daily exercise). The maximal score of 100 corresponds to all variables at target. Fewer points were assigned to higher blood pressure, worse HbA1c levels, less exercise, etc.

Secondary

MeasureTime frameDescription
LDL-cholesterol9 months
HbA1c9 monthsMeasure of glycemic control

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026